Tag - medicine-4

 
 

MEDICINE 4

Japan Times
COMMENTARY / World
Dec 1, 2020
A triumph of German innovation and immigration
The great advantage of BioNTech's approach is that it allows for the production of more than one billion vaccine doses within the space of just a few months.
Japan Times
WORLD
Nov 30, 2020
Moderna to seek U.S. and EU clearance for COVID-19 vaccine
The move came after a new analysis showed the vaccine was highly effective in preventing COVID-19 with no serious safety problems.
Japan Times
WORLD / Science & Health
Nov 29, 2020
COVID-19 drugs from Lilly and Regeneron raise access and timing concerns
Powerful drugs recently authorized by the U.S. that may prevent those at the earliest stages of COVID-19 from suffering severe disease present thorny new challenges, including who will get them and where they’ll be administered.
Japan Times
JAPAN / Science & Health
Nov 27, 2020
Ratio of medical staff gives Japan edge against COVID-19, OECD says
The nation is also helped by its better infrastructure, higher numbers of intensive care beds and higher government spending as a proportion of GDP.
Japan Times
COMMENTARY / World
Nov 27, 2020
Coronavirus is helping African economies compete
Africa's 54 countries now include seven of the globe's 10 fastest-growing economies, in part because the lethal virus may have improved their competitive advantage.
Japan Times
WORLD / Science & Health
Nov 26, 2020
After admitting error, AstraZeneca faces hard questions on vaccine
Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.
Japan Times
COMMENTARY / World
Nov 26, 2020
What a 95% effective vaccine could do is pretty exciting
A rough estimate based on the infectiousness of COVID-19 is that about 70% of the population would have to be immune for its spread to slow without any other preventative measures.
Japan Times
JAPAN / Science & Health
Nov 25, 2020
Japan's new ambassador to China to be quarantined for two weeks
According to sources familiar with his itinerary, the ambassador will travel to Beijing in a vehicle so he doesn't come into contact with others in a journey that will take eight hours.
Japan Times
JAPAN / Science & Health
Nov 25, 2020
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Japan Times
WORLD / Science & Health
Nov 25, 2020
Evidence builds that an early mutation made the pandemic harder to stop
There is no evidence that a coronavirus with the mutation causes more severe symptoms, kills more people or complicates the development of vaccines.
Japan Times
WORLD / Science & Health / FOCUS
Nov 24, 2020
Decades of work, and half a dose of fortune, drove Oxford vaccine success
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.
JAPAN
Nov 23, 2020
Japan aims to remove income cap on subsidies for fertility treatment
Prime Minister Yoshihide Suga said Monday the government aims to abolish the cap on income to make it easier for all couples to receive subsidies for fertility treatment as Japan faces a declining birth rate.
Japan Times
WORLD / Politics
Nov 23, 2020
G20 vows fair distribution of COVID-19 vaccines to all nations
At the virtual summit, Prime Minister Yoshihide Suga emphasized the importance of guaranteeing universal access by supplying treatment drugs and vaccines for COVID-19.
Japan Times
WORLD
Nov 23, 2020
U.S. plans first vaccinations in weeks, Operation Warp Speed chief says
Vaccinations against COVID-19 in the U.S. will "hopefully” start in less than three weeks, according to the head of the federal government’s program to accelerate a vaccine.
Japan Times
COMMENTARY / Japan
Nov 22, 2020
The new normal that will arise after COVID-19
In the post-COVID-19 world, the coronavirus should prove far less dangerous, eventually becoming as common as the flu. But that doesn't mean life will completely revert to the way it was.
Japan Times
COMMENTARY
Nov 22, 2020
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Japan Times
JAPAN / Media / MEDIA MIX
Nov 21, 2020
A frank conversation is needed on euthanasia
In October, New Zealand voters approved a referendum proposal to legalize medically assisted suicide, thus joining a small group of countries and territories that allow euthanasia under specific circumstances. The proposal sprang from a lawsuit brought by a lawyer dying from a brain tumor, and while...
Japan Times
WORLD / Science & Health
Nov 21, 2020
Two companies say their vaccines are 95% effective. What does that mean?
You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that's not how the math works.
Japan Times
JAPAN
Nov 21, 2020
10-year cancer survival rate in Japan rises to 58.3%
The survey has continually shown an improvement in life expectancy since the center started collecting data around 2000.
Japan Times
JAPAN
Nov 20, 2020
Hospitals in Japan's hard-hit areas stretched amid COVID-19 surge
There is concern that a rising trend in the number of severely ill patients could overwhelm hospitals, health care facilities and intensive care units, delaying critical care.

Longform

Traditional folk rituals like Mizudome-no-mai (dance to stop the rain) provide a sense of agency to a population that feels largely powerless in the face of the climate crisis.
As climate extremes intensify, Japan embraces ancient weather rituals